c-Myc Inhibits Macrophage Antimycobacterial Response in Mycobacterium tuberculosis Infection.
Edoardo Sarti, Cédric Dollé, Rebekka Wolfensberger, Katharina Kusejko, Doris Russenberger, Simon Bredl, Roberto F Speck, Melanie Greter, et al. (18 authors)
The Journal of infectious diseases · 2025-10
Abstract
BACKGROUND: Mycobacterium tuberculosis (MTB) remains a major cause of global mortality, yet natural immunity prevents disease in more than 90% of exposed individuals. Interferon gamma (IFN-γ) is a critical regulator of innate immunity and enhances macrophage antimicrobial responses.
METHODS: Using in vitro systems approaches, we compared the effects of IFN-γ exposure before versus after infection. We manipulated c-Myc in primary macrophages with a tetracycline-inducible lentiviral system. c-Myc expression was also analyzed in tissues from murine tuberculosis models and human granulomas.
RESULTS: Preinfection IFN-γ exposure primed macrophages for enhanced bacterial control, whereas postinfection exposure did not. We identified c-Myc signaling as a central determinant of macrophage antimycobacterial function. Inhibition of c-Myc via Omomyc enhanced bacterial control partly through mTORC1-dependent metabolic reprogramming and nitric oxide production. In vivo analyses, including murine models and human clinical histopathology, revealed strong associations between c-Myc expression, MTB persistence, and active tuberculosis.
CONCLUSION: c-Myc mediates immune privilege in MTB infection and represents a promising target for host-directed therapies to enhance macrophage function.
MeSH terms
- Animals
- Macrophages
- Mycobacterium tuberculosis
- Humans
- Mice
- Tuberculosis
- Interferon-gamma
- Proto-Oncogene Proteins c-myc
- Mice, Inbred C57BL
- Disease Models, Animal
- Female
- Signal Transduction
- Immunity, Innate
- Granuloma
- Nitric Oxide